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Aim of the study. Comparative assessment of the efficacy of transurethral Thulium:YAG laser 
vapoenucleation of prostate (ThuVEP). 
Materials and methods. 37 patients with average age  of 67 years underwent surgical  
treatment of  large BPH at the Department of urology and surgical nephrology, State University 
of Medicine and Pharmacy “Nicolae Testemițanu”. Patients were divided into two treatment 
groups: ThuVEP (17 patients) and open simple prostatectomy (Fuller-Freyer procedure) (20 
patients) and evaluated postoperatively at 3 months. Hemoglobin drop was also evaluated at 
the first postoperative day. 
Preoperative patients were investigated: PSA, IPSS, QoL, TRUS-P with PVR and Qmax. 
Patients inclusion criteria: Prostate Volume ≥80cm3, IPSS ≥16 and PVR ≥ 50ml, PSA≤4ng / 
ml, QoL> 4, Qmax <8ml / s. 
Results. Average duration of intervention: 79 min vs 63 min. The prostate volume decreased 
postoperative on average from 82,2 cm3 to 31,3 cm3 vs 83,4 cm3 to 31,9 cm3, there was an 
increase of average Qmax from 8,2 to 20.3 ml / s vs 8,4 to 21,1 ml / s, and a decrease in mean 
IPSS from 19,3 to 5.3 vs 20,1 to 5,4, and PVR diminished from 67.2 ml to 15,4 ml versus 68,1 
to 17,4 ml, respectively. The period of transitional macrohematuria was 2,1 days vs 5,3 days 
respectively. The duration of cateterization was 2,3 days in the first group and 8,3 days in the 
second group. Mean hemoglobin drop was 2,1g/l in Group 1 vs 3,4g/l in Group 2. 
Conclusions. ThuVEP is an effective alternative method in the treatment of large BPH. 
Immediate postoperative results of  ThuVEP are similar to the results in open simple 
prostatectomy (Fuller-Freyer procedure). It is to mention a high safety profile characteristic for 
ThuVEP and a reduced hemoglobin drop comparatively to clasic open surgery. 
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Introduction. Endometriosis is a benign gynecological estrogen-dependent disease 
characterized by endometrium-like tissue outside the uterus. The disease affects approx. 6-10% 
of women of reproductive age. The benign endometrial tumor also known as ’’chocolate cyst” 
affects 17-44% of women with endometriosis. Etiological theories explaining the endometrial 
lesions are: reflux of endometrial tissue via fallopian tubes during menstruation, coelomic 
metaplasia, vestiges of embryonic cells and lymphatic and vascular proliferation. The golden 
standard in diagnosis of endometrial tumors is laparoscopy. Transvaginal ultrasound does not 
help in initial diagnosis, but nonetheless can help in telling apart the endometrial from other 
benign ovarian tumors, while MRI helps in differentiating endometrial ovarian tumors from 
other ovarian cysts.   
Aim of the study.  Evaluation of risk factors and methods of diagnosis of endometrial ovarian 
tumors.   
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Materials and methods..  Lot of patients: 27 patients with endometrial ovarian tumors who 
were hospitalized and received treatment at PMSI OI of the Republic of Moldova between 
2014 and 2019.   
Results. Total number of patients enrolled in the study: 27 patients, 25-45 years (age of highest 
incidence) - 15 patients (55,5%). The most frequent symptoms: pelvic pain - 27 patients 
(100%), dysmenorrhea - 9 patients (33,3%), dyspareunia- 5 patients (18,51%), metrorrhagia - 
3 patients (11,1%).Bimanual examination of 12 patients (44,4%), revealed a smooth, elastic 
mass. According to laboratory data, 19 patients (70,37%) showed high CA 125 values, and 14 
patients (51,8%) high estradiol values. Diagnostic imaging: ultrasound - 27 patients (100%), 
CT -7 patients (25,92%), MRI - 3 patients (11,1%). Laparoscopic methods: diagnostic 
laparoscopy - 12 patients (44,4%). All patients have received surgical treatment: surgery under 
laparoscopy - 12 patients (44,4%), laparotomy - 15 patients (55,5%).   
Conclusions.  1.Age and high estrogen levels are among the main factors which lead to 
endometrial ovarian tumors.  2.Pelvic pain is the main symptom shown by patients followed 
by dysmenorrhea, dyspareunia, and metrorrhagia.  3.Laparoscopy is the golden standard in the 
diagnosis of endometrial ovarian tumors.   
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Introduction.  Metastatic ovarian cancer is a serious worldwide public health problem, with 
one of the highest potential for lethality among all tumors. It is an advanced malignancy, or 
secondary tumor, with primary other organs, most commonly the gastrointestinal tract and 
mammary gland, stomach, colon, appendix, uterus, lung. At present, the treatment of metastatic 
ovarian tumors consists of several successive stages: surgical treatment, chemotherapy and 
radiotherapeutic treatment. Patients with a metastatic limit only in the ovary have a favorable 
prognosis, or usually. Adjuvant chemotherapy after metastasis resection offers survival 
benefits in gastric and colorectal cancer. The ovary is a frequent site of involvement for 
metastases. Ovarian involvement is observed at autopsy in approximately 10% of breast cancer 
cases. Metastasis is bilateral around 80% of patients. About 5-30% of ovarian cancers are 
metastatic malignancies.   
Aim of the study.  To study the techniques and principles of treatment for metastatic ovarian 
tumors   
Materials and methods..  Lot of patients: 53 patients with metastatic ovarians tumors were 
hospitalized and treated in IMSP IO from Moldova during 2012-2019   
Results. Total enrolled: 53 patients, age with the highest incidence - 41-50 years - 18 patients 
(33.9%) Histological distribution: signet ring cell - 26 patients( 49.1%), adenocarcinoma – 24 
patients ( 45.2%), clear cell carcinoma - 3 patients (5.66%). After the primary outbreak - the 
highest incidence for the stomach cancer - 25 patients (47.1%) and uterus cancer- 17 patients 
(32.07%).For the colorectal cancer the incidence is 9.43%- 5 patients, uterin cervical cancer-
3.77%- 2 ,mammary gland cancer-5,66%- 3 patients and for cancer without clarification-1,88 
%- 1 patient. Bilaterality is prevalent in our study with 62.2% (33 persons)  Of them treated 
surgically: 53 patients-100% ,treated only with adjuvant chemotherapy: 40 patints- 75,47 %, 
